Clinical Trial

3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class IV and 25 veneers will be included in the evaluation. Research data and pictures will be provided for each patient pre-op and at 7 days (baseline, 6 months, 12 months and 24 months. Evaluation will be conducted by two calibrated evaluators different from the operator according to FDI clinical criteria.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-12; most recent amendment 2026-02-26.
Trial Details
NCT Number NCT07128589
Lead Sponsor New York University
Conditions Dental Restoration, Dental Veneers
Enrollment 75 participants
Start Date 2025-08-07
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-27